Mabwell (Shanghai) Bioscience Co., Ltd. Stock
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.91 CNY | -0.96% | -0.75% | +0.67% |
May. 07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
Apr. 29 | Mabwell Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 341M 47.05M | Sales 2025 * | 1.09B 150M | Capitalization | 12.97B 1.79B |
---|---|---|---|---|---|
Net income 2024 * | -894M -123M | Net income 2025 * | -622M -85.89M | EV / Sales 2024 * | 38.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-14.7
x | P/E ratio 2025 * |
-21.2
x | Employees | 1,491 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.33% |
1 day | -0.96% | ||
1 week | -0.75% | ||
Current month | -6.96% | ||
1 month | -3.91% | ||
3 months | +16.78% | ||
6 months | +19.37% | ||
Current year | +0.67% |
Managers | Title | Age | Since |
---|---|---|---|
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Jin Hua
DFI | Director of Finance/CFO | 43 | 23-06-26 |
Xin Du
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Ling Li
BRD | Director/Board Member | 70 | 20-10-10 |
Chun Shan Tang
BRD | Director/Board Member | 55 | 19-03-31 |
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 32.91 | -0.96% | 1,867,660 |
24-05-22 | 33.23 | +0.51% | 1,293,421 |
24-05-21 | 33.06 | -0.93% | 988,828 |
24-05-20 | 33.37 | -0.68% | 1,243,677 |
24-05-17 | 33.6 | +1.33% | 982,850 |
End-of-day quote Shanghai S.E., May 22, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.67% | 1.82B | |
+11.76% | 116B | |
+12.16% | 106B | |
-8.02% | 23.89B | |
-2.68% | 21.58B | |
-10.86% | 18.96B | |
-40.50% | 16.96B | |
-13.51% | 16.33B | |
+7.10% | 14.14B | |
+33.51% | 12.02B |
- Stock Market
- Equities
- 688062 Stock